QS/1, LDM partner on CarePoints patient messaging system
SPARTANBURG, S.C. QS/1 is teaming up with LDM Group to offer pharmacies a new service that will allow customers more access and information to their healthcare.
The service, called the CarePoints patient messaging system, gives pharmacies the ability to print patient specific material that offers suggestions for over-the-counter medications that complement the prescription, or even suggest a prescription that could be more beneficial for the patient. The pharmacy system uses de-identified information about the patient to cross-reference which material to print, meaning it is completely HIPAA compliant.
“Let’s assume a patient comes into a pharmacy and gets a prescription for a medicine they must take twice a day,” Mike Coyne, vice president of LDM Group explains. “The pharmacy system would know to print information about an alternative drug that is taken only once a day.”
Pharmacies can also take advantage of several “added value” benefits with this service. Pharmacies can print required Medication Guides for patients prescribed specific prescription drugs. This saves time from having to determine which drugs require the MedGuide and manually printing it.
Independent and regional chain pharmacies can also use the CarePoints patient messaging system to target in-store promotions, such as vaccination clinics.
FDA issues final approval for Perrigo’s generic Zyrtec
ALLEGAN, Mich. The Food and Drug Administration has given approval to Perrigo to manufacture and market cetirizine hydrochloride syrup in 1mg per milliliter strength.
The syrup, a generic version of McNeil Consumer Healthcare’s Zyrtec syrup, relieves symptoms of allergic rhinitis.
“This approval reflects both our strategy to be first to market with important products and the unique position of the company both in front of and behind the pharmacy counter,” Perrigo Chairman and chief executive officer Joseph Papa said.
Pfizer, which originally marketed Zyrtec, reported that it had sales of $1 billion in 2007. Pfizer lost U.S. exclusivity for Zyrtec in January, according to its annual report.
Nestea introduces green tea with higher antioxidant concentration
ATLANTA Iced Tea brand Nestea announced today the launch of its new Green Tea Citrus and Diet Green Tea Citrus products with 50 percent more antioxidants than before, as well as a brand new look.
The new varieties combine all-natural fruit flavors and the natural goodness of tea, largely in response to consumer health awareness. Both products now contain 50 percent more natural tea antioxidants, with 96 milligrams of flavonoid antioxidants per eight fluid ounce serving.
“As summer approaches, it is the perfect time to introduce products for consumers who want to quickly revitalize their day,” said Penny McIntyre, senior vice president and general manager of coffee and tea for Coca-Cola North America. “Nestea offers delicious, simple blends of tea and natural fruit flavors. Our new Green Tea Citrus products with even more antioxidants are great additions to our line of refreshing teas.”
The new packaging features dynamic graphics that call attention to the antioxidant content and all-natural fruit flavors. Nestea’s Iced Tea with Lemon and Diet Iced Tea with Lemon flavors come in 20 ounce and half-liter plastic bottle 12-packs. The Iced Tea with Lemon also comes in aluminum cans (regular and diet) and 2-liter plastic bottles (regular).